Fibronectin1-Expressing Subicular Circuits Selectively Govern the Retrieval of Novel Object Recognition.

Saved in:
Bibliographic Details
Title: Fibronectin1-Expressing Subicular Circuits Selectively Govern the Retrieval of Novel Object Recognition.
Authors: Fei F; Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.; Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China., Shi J; Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China., Xi J; Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China., Xu Y; Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China., Ying S; Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China., Fan X; Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China., Lu W; Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China., Li Z; Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China., Li M; Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China., Wang Y; Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China., Cheng L; Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China., Yang L; Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China., Xu L; Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China., Chen Z; Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.; Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China., Xu C; Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China., Wang Y; Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key Laboratory of Neuropsychopharmacology, School of Pharmaceutical Sciences, & First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, China.; Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, School of Medicine, Zhejiang University, Hangzhou, China.
Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2026 Jul; Vol. 13 (39), pp. e16399. Date of Electronic Publication: 2026 Apr 15.
Publication Type: Journal Article
Journal Info: Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844 (Electronic) Linking ISSN: 21983844 NLM ISO Abbreviation: Adv Sci (Weinh) Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2198-3844
DOI:10.1002/advs.202516399